InsiderTrades

Form 4 for ICUI ICU MEDICAL INC/DE

Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-15 · accession 0001698998-24-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-18 2024-03-15 ICUI Woolson Daniel VP, GM-Infusion Capital F - Tax $98.08 -1,294 15.6K -8% -$126.9K
D 2024-03-18 2024-03-15 ICUI Woolson Daniel VP, GM-Infusion Capital M - OptEx $0.00 +2,923 16.9K +21% $0
D 2024-03-18 2024-03-15 ICUI Woolson Daniel VP, GM-Infusion Capital M - OptEx $0.00 -2,923 5,847 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-15 F D 1,294 $98.08 15,609 D — —
2 Common Common Stock 2024-03-15 M A 2,923 $0.00 16,903 D — — (F1) These Securities are Performance-based Restricted Stock Units (PRSU).
3 Derivative Performance Shares 2024-03-15 M D 2,923 $0.00 5,847 D $0.00 · — to 2026-03-15 2,923 Common Stock (F1) These Securities are Performance-based Restricted Stock Units (PRSU). (F2) There is neither a purchase price nor an exercise price for the PRSUs. (F3) One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date.